Spire Wealth Management Gritstone Bio, Inc. Transaction History

Spire Wealth Management

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 18, 2022	SELL	$4.03 - $12.19 $7,455 - $22,551	-1,850 Closed	0 $0
Q4 2021 Jan 14, 2022	BUY	$8.76 - $13.71 $16,206 - $25,363	1,850 New	1,850 $24,000
Q2 2021 Jul 26, 2021	SELL	$8.13 - $10.2 $40,650 - $51,000	-5,000 Closed	0 $0
Q1 2021 May 21, 2021	BUY	$4.07 - $27.11 $20,350 - $135,550	5,000 New	5,000 $56,000

35.4M

395K

132K

Ticker GRTS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 73,006,896
Market Cap $2.19M
Description
Gritstone bio, Inc., a clinical-stage biotechnology company, engages in developing immunotherapies against multiple cancer types and infectious diseases. Its lead product candidate is GRANITE, a neoantigen-based immunotherapy for the treatment of solid tumors, including metastatic non-small cell lung cancer, as well as gastroesophageal, bladder ...

Get notified when there are updates to the investment portfolio of Spire Wealth Management, based on Form 13F filings with the SEC.

Stay updated on Spire Wealth Management with notifications on news.